A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ohnishi Neurological Center
Akashi, Hyōgo, Japan
Yoshihiro Kuga, MDRecruiting
- University of Maryland, Baltimore
Baltimore, Maryland, United States
Howard Eisenberg, MDRecruiting - Weill Cornell Medicine
New York, New York, United States
Michael Kaplitt, MD PhDRecruiting - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Casey Halpern, MDRecruiting - University of Texas Southwestern Medical Center
Dallas, Texas, United States
Bhavya Shah, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jan 2023
- Primary completion
- 31 Jul 2029
- Completion
- 31 Jul 2029
- Last update posted
- 20 Mar 2026
- Registered enrollment
- 60
- Registry id
- NCT05539196
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.